|
|
|
|
|
|
|
03.09.25 - 13:02
|
Precigen Announces Up to $125 Million Non-Dilutive Financing (PR Newswire)
|
|
|
$100 million funded at close fortifies balance sheet and supports robust US commercialization of PAPZIMEOS, as well as potential expansion into international markets and the pursuit of pediatric and other HPV-related indications GERMANTOWN, Md., Sept. 2, 2025 /PRNewswire/ -- Precigen, Inc.......
|
|
|
|
|
|
|
|
|
|
|
|
|
18.08.25 - 04:57
|
FDA Approves Therapy For Rare Disease Without Randomized Trial Data (ZeroHedge)
|
|
|
FDA Approves Therapy For Rare Disease Without Randomized Trial Data
Authored by Zachary Stieber via The Epoch Times (emphasis ours),
The Food and Drug Administration on Aug. 14 approved a therapy for a rare disease called recurrent respiratory papillomatosis (RRP).
The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times
Regulators cleared Papzimeos, an immunotherapy made by Precigen, citing data from a single-arm, open-label trial that looked at how it performed in adults with RRP and who needed at least three surgeries a year.
Patients received four injections of the therapy over 12 weeks following surgical procedures.
About half of the participants needed no surgery in the year following treatment. The safety profile was also deemed favorable.
“Randomized trials are not always needed to approve medical products and this approval is proof of that philosophy,” Dr. Vinay Prasad, director of the FDA's Center for Biologics Evaluation ...
|
|
|
15.08.25 - 18:01
|
XFRA: I5X: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
PRECIGEN INC. I5X US74017N1054
AB/FROM ONWARDS 15.08.2025 17:51 CET...
|
|
|
|
|
|
|
|
|
15.08.25 - 08:45
|
XFRA: I5X: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
PRECIGEN INC. I5X US74017N1054 BAW/UFN...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
